Slow hematological recovery in children with IBD-associated anemia in cases of expectant management

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 6, 2010, Pages 708-713

  Pels, Lise P M ^a   Van De Vijver, Els ^a   Waalkens, Herman J ^b   Uitentuis, Jan ^c   Jong, Gieneke Gonera De ^d   Van Overbeek, Lidy At ^e   Norbruis, Obbe F ^f   Rings, Edmond Hhm ^a   Van Rheenen, Patrick F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

^c MEDICAL CENTER LEEUWARDEN   (Netherlands)

^d Wilhelmina Ziekenhuis   (Netherlands)

^e Scheper Ziekenhuis   (Netherlands)

^f ISALA HOSPITAL   (Netherlands)

Author keywords

anemia; children; inflammatory bowel diseases; iron

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL EVALUATION; ENTERITIS; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ANEMIA; ANEMIA, IRON-DEFICIENCY; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; ENTERAL NUTRITION; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; TREATMENT OUTCOME;

EID: 78650510832     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181da4d8b     Document Type: Article

References (27)

1. Gasche C, Lomer MC, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut 2004;53:1190-7.
2. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: A systematic review of the literature. Am J Med 2004;116 (Suppl 7A):44S-9S.
3. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
4. Wells CW, Lewis S, Barton JR, et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006;12:123-30.
5. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007;13:1545-53.
6. Thayu M, Mamula P. Treatment of iron deficiency anemia in pediatric inflammatory bowel disease. Curr Treat Options Gastroenterol 2005; 8:411-7.
7. Grand RJ, Ramakrishna J, Calenda KA. Inflammatory bowel disease in the pediatric patient. Gastroenterol Clin North Am 1995;24:613-32.
8. Inflammatory bowel disease in children and adolescents: Recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 2005;41:1-7.
9. Nathan DG, Orkin SH, Lock AT, Ginsburg D. Nathan and Oski's Hematology of Infancy and Childhood. Philadelphia: Saunders; 2003.
10. Iron deficiency anaemia; assessment, prevention and control. In: A Guide for Programme Managers. WHO/NHD/01.3. Geneva: World Health Organization; 2010.
11. Chang J, Bird R, Clague A, et al. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients. Pathology 2007;39:349-53.
12. Guidelines on Diagnostics and Treatment of Inflammatory BowelDisease in Children. [in Dutch] Amsterdam: Dutch Society of Pediatrics; 2008.
13. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
14. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: A prospective multicenter study. Gastroenterology 2007;133:423-32.
15. Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008;103:1299-307.
16. Agarwal R. Nonhematological benefits of iron. Am J Nephrol 2007; 27:565-71.
17. Brownlie T, Utermohlen V, Hinton PS, et al. Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Clin Nutr 2002;75:734-42.
18. Haas JD, Brownlie T. Iron deficiency and reduced work capacity: A critical review of the research to determine a causal relationship. J Nutr 2001;131 (2S):676S-88S.
19. Ploeger H, Sears R, Issenman R, et al. Exercise capacity in pediatric patients with inflammatory bowel disease. Paper presented at: Annual meeting of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; November 12-14, 2009; National Harbor, MD.
20. Macdougall IC. Quality of life and anemia: The nephrology experience. Semin Oncol 1998;25 (3 Suppl 7):39-42.
21. Gisbert JP, Bermejo F, Pajares R, et al. Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement. Inflamm Bowel Dis 2009;15: 1485-91.
22. Gasche C. Anemia in IBD: The overlooked villain. Inflamm Bowel Dis 2000;6:142-50.
23. Erichsen K, Hausken T, Ulvik RJ, et al. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 2003;38:543-8.
24. Semrin G, Fishman DS, Bousvaros A, et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006;12:1101-6.
25. Erichsen K, Ulvik RJ, Grimstad T, et al. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005;22:831-8.
26. Erichsen K, Ulvik RJ, Nysaeter G, et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005;40:1058-65.
27. Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: The ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008;103:1182-92.